Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Chua

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Performance Characteristics for Physiological Measures of Progressive Pulmonary FibrosisChad A Newton, Ashwatha Thenappan, Gabrielle Y Liu, et al.
Gut|June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panelShahida Din, Alexandra Kent, Richard C Pollok, et al.
Tuberculosis and Respiratory Diseases|June 10, 2025
Pharmacoeconomic inequalities in access to antifibrotic treatment for interstitial lung disease in the Asia-Pacific regionFelix Chua, Larry Ellee Nyanti, Shirin Tan, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
The European Respiratory Journal|December 5, 2024
Childhood interstitial lung disease survivors in adulthood: a European collaborative studyEffrosyni D Manali, Matthias Griese, Nadia Nathan, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Performance Characteristics for Physiological Measures of Progressive Pulmonary FibrosisChad A Newton, Ashwatha Thenappan, Gabrielle Y Liu, et al.
Gut|June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panelShahida Din, Alexandra Kent, Richard C Pollok, et al.
Tuberculosis and Respiratory Diseases|June 10, 2025
Pharmacoeconomic inequalities in access to antifibrotic treatment for interstitial lung disease in the Asia-Pacific regionFelix Chua, Larry Ellee Nyanti, Shirin Tan, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
The European Respiratory Journal|December 5, 2024
Childhood interstitial lung disease survivors in adulthood: a European collaborative studyEffrosyni D Manali, Matthias Griese, Nadia Nathan, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Pageof 8